🎉 Our brilliant new #SurgOnc clinical fellows have already been at work for a month! Welcome to Toronto and the program @aleborghiMD 🇮🇹 @DrShellyLuu 🇨🇦 @julielaMD 🇨🇦 & Alberto Riojas 🇲🇽🌟

Major step forward toward cure for diabetes in trial led by Dr Trevor Reichman, Director of Pancreas & Islet Transplant Program ⁦@UHNTransplant⁩ ⁦@UHN_Surgery⁩ ⁦@UHN_Research⁩ ⁦@UHN⁩

🧒🩺 New from Drs. @AmandaJensenMD & Carlos Esquivel in @LTxJournal: In pediatric liver transplants, choledochoduodenostomy (CD) had the fewest biliary complications—lower stricture & leak rates than traditional options. CD is safe & may be superior. 🔗:

IPMN 🍇 without HRS and long term risk of cancer development 🇯🇵 2.5k pts > 5 years surveillance 🫧 IPMN size and growth predict cancer within 5 years 🤏 MPD diameter at 5 years predicts cancer after 5 years https://t.co/dNeBthc6QU

Pancreatic cancer, often linked to smoking, obesity and diabetes, is predicted to become the 2nd leading cause of cancer-related death by 2030. A recent Seminar discusses the need for novel therapies & future directions for research: https://t.co/IQNCCl8FJY

Deceased donor liver utilisation & assessment, consensus guidelines from ELITA including practical considerations/recommendations on: 🚧 adverse outcomes to be used to define suitability for #transplantation with conventional SCS alone ⚖️ donor & graft factors to define liver

Normothermic regional perfusion (NRP) boosts organ recovery, but ethical concerns slow adoption. A scoping freely downloadable review explores key debates on donor harm, consent, trust, & justice. Can ethical challenges be resolved? #TXPforAll #OpenAccess

Update on Portopulmonary hypertension guideline by International liver transplantation society 📌Hemodynamic definitions 📌Management approaches 📌POPH MELD exception criteria 📌Long-term outcomes #livertwitter https://t.co/lJFuzY9gF1 @AnjanaPillaiMD @HowardTLeeMD @LizzieAbyMD

The hard part of the whipple is done 💪time for the H-J !!! But do not let the attention drop… it can be tricky! 😅 🎥 Video grading bile duct anastomoses during robot PD 🐸 Bile leak rate 7% predicted by video! 🤖 Tool for teaching / learning curve https://t.co/LLUg7rysIA

Co-producing a health advocate intervention for pediatric liver transplant recipients using human-centered design @UCSFLiverCenter @DoctorSharad @johnbucuvalas @JVittorioMD https://t.co/RwnYzv8C5M

ChatGPT-4 demonstrates strong accuracy in grading surgical complications using the Clavien-Dindo classification. While it holds promise for automating postoperative data analysis, human oversight is still critical. https://t.co/GmUWWYc0VV

Treating livers ex-situ before LT using a MSC bioreactor: ⛑️ avoid MSC direct administration 🎯 reduce IRI in LT pathway ☄️ organ NMP treatment with a proven multistep experimental approach A great collaborative study @policlinicoMI & @HPDsurgery https://t.co/GsPni8a3KC

Long term natural history of BD IPMN 🍇 beyond 10 years of follow-up 🧐 316 patients 🇺🇸 median FU 13 years 🚨 At 10 years 24% WF / 8% Malignancy 📈 Risk of cancer overall 9X population 🎞️ Dynamic evaluation needed to stratify risk! https://t.co/MNJmmYKbSq

Thrilled that my project "Epa-Rity" has been selected for @FondCariplo grant 'Inequalities Research.' Because "réparer les vivants" requires more than just technology and medicine—it means ensuring access to care for everyone and identifying where the system falls short

New Review - The liver–brain axis in metabolic dysfunction-associated steatotic liver disease https://t.co/SvLIg7642j #LiverTwitter #MedTwitter

🆕EASL Clinical Practice Guidelines on the management of #hepatocellularcarcinoma❗️ ✅Updated advice for managing patients with #HCC & comprehensive review of pertinent data Full text👉 https://t.co/IAMvBDv0CT #CPGs #LiverTwitter @EASLnews @EASLedu @AleksanderKrag

🆕EASL Clinical Practice Guidelines on #LiverTransplantation❗️ ✅Focus on developments since the previous EASL guidelines published in 2016 Full text👉 https://t.co/PhHhCpXCUv #CPGs #LiverTwitter @EASLnews @EASLedu @AleksanderKrag

REVIEW Zanuso V et al. The rapidly evolving landscape of HCC: Selecting the optimal systemic therapy. #LiverTwitter https://t.co/vnLBr1FosF

And best poster with dr. Loglio from BG Hospital in a collaborative study with @policlinicoMI . Thanks to all the colleagues that took part to the study! Especially to @LucaDelPrete9 and @elo_franchi

REVIEW Obesity management for the hepatologist—What to do, how to do it and why? by @kymwatt @mqkMD et al. #LiverTwitter https://t.co/WrOY1h405f